A 5-aminosalicylic acid (5-ASA) drug switch program switching from 5-ASA to sulfasalazine was instituted for insured patients with ulcerative colitis. Unanticipated barriers limited the number of patients who switched, but significant cost savings were still obtained.
An oral chemotherapy cycle management program offers clinical support, reduces medication wastage, and provides management of adverse effects to realize cost savings for payers and patients.
An analysis of administrative claims showed increasing rates of heroin overdose among an insured population and opportunities for interventions during healthcare encounters before overdose.
Retrospective evaluations of electronic health records and claims databases to assess clinical outcomes and costs associated with evidence-based pathways in colon cancer.
Only 19% of patients in this sample had good diabetes control based on their tested glycated hemoglobin levels. Patients diagnosed with mental health conditions in this study were more likely to have good diabetes control.
Although patients who refuse post acute care services are relatively young, well educated, and healthy, they are twice as likely to have 30- and 60-day readmissions compared with acceptors of services.
Prostate-specific antigen screening was highest among African American men and those concerned about prostate cancer and lowest when physicians did not discuss the test.
An examination of hospitalization patterns in patients with multiple sclerosis with a focus on the association with time and patient characteristics.
A study evaluating the association between hospital sharing of electronic health record diagnostic information and hospital quality using Hospital Compare scores.
From 2001 to 2011, the US Food and Drug Administration approved 9 single-enantiomer drugs with racemic precursors. None showed pre-approval evidence of improved efficacy over the racemic precursor.
In a longitudinal study, the authors find that food insecurity is associated with greater emergency department visits, inpatient admissions, and length of stay. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.
Ten percent of patients abandon newly initiated oral oncolytics at the pharmacy. Patients facing higher cost sharing or increased concurrent prescription activity have a higher abandonment rate.